Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-06-19
1999-12-21
Huang, Evelyn Mei
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514443, 514448, 514559, 514560, 514563, 514568, 514569, 514729, A61K 31455, A61K 3138, A61K 3120, A61K 3159
Patent
active
060049871
ABSTRACT:
The present invention relates to the use of at least one ligand which is specific for RXR receptors, in the preparation of a pharmaceutical composition to be administered systemically and intended to increase the cellular proliferation and/or differentiation modulatory activity of a ligand for at least one receptor of the superfamily of steroidal/thyroidal receptors, other than a ligand which is specific for the RXR receptors, and which can heterodimerize with the RXRs, which is applied topically.
REFERENCES:
Mol. Cell. Biol., vol. 15, No. 12, 1995, pp. 6481-6487.
J. Biol. Chem., vol. 267, No. 31, 1992, pp. 22010-22013.
Hashimoto Y et al. Biochem. Biophys. Res. Commun. 166(3), 1300-1307, Feb. 1990.
Demarchez Michel
Jomard Andre
Centre International de Recherches Dermatologiques Galderma
Huang Evelyn Mei
LandOfFree
Use of ligands which are specific for RXR receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of ligands which are specific for RXR receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ligands which are specific for RXR receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505581